WAVEMAN · COMPANY

SRTS · Sensus Healthcare, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

SRTS

Name: Sensus Healthcare, Inc. (SRTS) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Sensus Healthcare, Inc.

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0001494891

C-SUITE BUYING · 1☆ WATCH

INSIDER NET · 180D

$568.5K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

-34.3%

XBRL, annual

NET MARGIN

-28.1%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$568.5K over 180 days

+$563.5K over 90 days

more than 90% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

11 funds added or opened last quarter

below 84% of Medical Devices

REVENUE

-34.3% year over year

below 93% of Medical Devices

MARGIN

-28.1% net margin

below 64% of Medical Devices

BUYBACKS

$300.0K repurchased, FY to 2025-12-31

below 92% of Medical Devices

SHORT

no short interest reported

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -3.8%

-3.8%12M

INSIDER BUY

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $568.5K bought by insiders over 180 days, 11 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Sensus Healthcare, Inc. insiders bought a net $568.5K of stock across 71 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Sachetta Eric

Director

BUY

2026-08-31

27,304.0

$96.6K

Sachetta Eric

Director

BUY

2026-08-28

37,537.0

$129.0K

Sachetta Eric

Director

BUY

2026-08-27

10,925.0

$34.8K

Sachetta Eric

Director

BUY

2026-08-26

9,708.0

$31.9K

Sachetta Eric

Director

BUY

2026-08-24

34,697.0

$112.9K

71 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 66 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Pacific Ridge Capital Partners, LLC

789,675.0 sh

$2.4M

VANGUARD CAPITAL MANAGEMENT LLC

660,402.0 sh

$2.0M

DIMENSIONAL FUND ADVISORS LP

316,121.0 sh

$954.8K

Divisadero Street Capital Management, LP

278,485.0 sh

$841.0K

RENAISSANCE TECHNOLOGIES LLC

242,334.0 sh

$731.8K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

M3Sixty Income and Opportunity Fund

$575.8K POSITION · AS OF 2026-02-28

3.3%

North Star Micro Cap Fund

$516.2K POSITION · AS OF 2026-02-28

0.3%

Adara Smaller Companies Fund

$1.3M POSITION · AS OF 2026-02-28

0.2%

ACUITAS US MICROCAP FUND

$44.7K POSITION · AS OF 2026-03-31

0.0%

iShares Micro-Cap ETF

$135.9K POSITION · AS OF 2026-03-31

0.0%

1290 VT Micro Cap Portfolio

$9.2K POSITION · AS OF 2026-03-31

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Executive pay vs shareholder return · Mr. J Sardano

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2024

$1.3M

$963.8K

-4%

—

2023

$687.6K

$404.8K

-68%

—

2022

$754.4K

$421.9K

+3%

—

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$27.5M	$41.8M	$24.4M	$44.5M
GROSS PROFIT	$11.9M	$24.4M	$14.1M	$29.6M
OPERATING INCOME	$-10.3M	$8.1M	$-382.0K	$14.8M
NET INCOME	$-7.7M	$6.6M	$485.0K	$24.2M
EPS (DILUTED)	-0.47	0.41	0.03	1.46
OPERATING CASH FLOW	$528.0K	$-831.0K	$-2.1M	$-1.4M
CASH	$22.1M	$22.1M	$23.1M	$25.5M
BUYBACKS	$300.0K	—	$27.0K	$3.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE